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ABSTRACT
Background The effects of COVID- 19 on the shift to 
remote consultations remain to be properly investigated.
Objective To quantify the extent, nature and clinical 
impact of the use of telepsychiatry during the COVID- 19 
pandemic and compare it with the data in the same 
period of the 2 years before the outbreak.
Methods We used deidentified electronic health 
records routinely collected from two UK mental health 
Foundation Trusts (Oxford Health (OHFT) and Southern 
Health (SHFT)) between January and September in 2018, 
2019 and 2020. We considered three outcomes: (1) 
service activity, (2) in- person versus remote modalities 
of consultation and (3) clinical outcomes using Health of 
the Nation Outcome Scales (HoNOS) data. HoNOS data 
were collected from two cohorts of patients (cohort 1: 
patients with ≥1 HoNOS assessment each year in 2018, 
2019 and 2020; cohort 2: patients with ≥1 HoNOS 
assessment each year in 2019 and 2020), and analysed 
in clusters using superclasses (namely, psychotic, non- 
psychotic and organic), which are used to assess overall 
healthcare complexity in the National Health Service. All 
statistical analyses were done in Python.
Findings Mental health service activity in 2020 
increased in all scheduled community appointments 
(by 15.4% and 5.6% in OHFT and SHFT, respectively). 
Remote consultations registered a 3.5- fold to 6- fold 
increase from February to June 2020 (from 4685 to a 
peak of 26 245 appointments in OHFT and from 7117 
to 24 987 appointments in SHFT), with post- lockdown 
monthly averages of 23 030 and 22 977 remote 
appointments/month in OHFT and SHFT, respectively. 
Video consultations comprised up to one- third of 
total telepsychiatric services per month from April to 
September 2020. For patients with dementia, non- 
attendance rates at in- person appointments were higher 
than remote appointments (17.2% vs 3.9%). The overall 
HoNOS cluster value increased only in the organic 
superclass (clusters 18–21, n=174; p<0.001) from 2019 
to 2020, suggesting a specific impact of the COVID- 19 
pandemic on this population of patients.
Conclusions and clinical implications The rapid 
shift to remote service delivery has not reached some 
groups of patients who may require more tailored 
management with telepsychiatry.
BACKGROUND
Telepsychiatry is the delivery of psychiatric assess-
ments or follow- up interviews from a distance using 
technologies such as telephone calls, audio and 
video digital platforms, and healthcare monitoring 
devices.1 After years of protracted efforts to imple-
ment digital transformation in the National Health 
Service (NHS),2 the COVID- 19 pandemic, and its 
associated UK- wide lockdown, led to near- overnight 
adoption of telepsychiatric services in clinical 
care. This unavoidable transition has undoubt-
edly ensured continuity of mental healthcare for 
patients.3 However, the impact of this profound 
shift, in terms of clinical effectiveness and patient 
satisfaction, and of the pandemic on patients, clini-
cians and services remains to be quantified.4
Rapid reporting of country- specific, high- quality 
evidence is mandatory to inform relevant stake-
holders at a time of unprecedented transformations 
in healthcare delivery. The wide- ranging impact 
of telepsychiatry on mental health service use and 
outcomes of care can be analysed efficiently with 
the UK’s electronic health records (EHR) infra-
structure. The Clinical Record Interactive Search 
(CRIS) provides an automated platform on which 
to access secure, deidentified, real- world EHR data 
and gain clinically meaningful insights into changes 
at the service and individual patient levels.5 Previous 
studies have assessed the impact of the pandemic on 
broad population- level mental health outcomes,6 
but few studies have quantified service- level and 
patient- level changes with a focus on telepsychi-
atry. Stewart and colleagues used CRIS to quan-
tify pandemic- related changes in adult community 
mental health and home treatment teams.7 This 
study was, however, limited to the analysis of data 
from one Trust only and between 2019 and 2020, 
making it difficult to differentiate the impact of the 
COVID- 19 pandemic from general trends in the 
population.
To overcome these shortcomings and increase 
clinical validity and generalisability of findings, we 
conducted a study using EHR data from two UK 
NHS Trusts over a 3- year evaluation period. Our 
aim was to assess the impact of the COVID- 19 
copyright.
 on O










ealth: first published as 10.1136/ebm






2 Hong JSW, et al. Evid Based Ment Health 2021;0:1–6. doi:10.1136/ebmental-2021-300287
Digital mental health
pandemic on mental health services by quantifying the extent, 
nature and patient- level impact of the shift to telepsychiatry.
METHODS
In May 2020, we contacted two NHS Trusts across England, 
Oxford Health NHS Foundation Trust (OHFT) and Southern 
Health NHS Foundation Trust (SHFT), which agreed to partici-
pate in the study. OHFT provides specialist mental health, phys-
ical health and social care services, covering a population of 1.9 
million people across Oxfordshire, Buckinghamshire, Swindon, 
Wiltshire, Bath and North East Somerset. SHFT provides 
specialist mental health services, learning disability services, social 
care and integrated community healthcare services covering 1.8 
million people in Hampshire, excluding Portsmouth City, with 
a mixture of urban city, suburbia and rural communities. The 
two Trusts operated different local EHR systems: CareNotes in 
OHFT and Servelec Open Rio in SHFT.
Using Structured Query Language (SQL), deidentified mental 
healthcare data were extracted from local EHR systems by local 
Data Science Teams (FS, TS, PP, TE) for all patients accessing 
mental health services at OHFT and SHFT between 1 January 
and 30 September in 2018, 2019 and 2020 (see online supple-
mental appendix for data plan, variables and definitions, and 
services/teams). The same 9- month period across three different 
years was selected to capture the key moments of the COVID- 19 
pandemic before and after the first national lockdown on 23 
March 2020, and to facilitate high- level serial comparisons 
across equivalent time frames. The period of analysis was limited 
to this 9- month period as the focus of the study was on the 
acute effects of a rapid, system- wide service transformation (ie, 
3 months before and 6 months after the national lockdown). 
The full study protocol is available in the online supplemental 
appendix. NHS Trust approval was provided by each partici-
pating site. Data handling was compliant with NHS Informa-
tion Governance regulations which include the Data Protection 
Act. A Patient and Public Involvement representative (RE) was 
involved in discussions during the planning, analysis and manu-
script writing phases of the project.
HoNOS data
For the analysis of clinical outcomes, we used the HoNOS data 
(as they are routinely collected in the NHS) and identified two 
cohorts of patients at OHFT. SHFT could not contribute to this 
analysis, as the Trust does not readily store cluster- level HoNOS 
scores in an anonymised format (see below for a description of 
clusters). It was therefore not feasible to replicate the HoNOS 
analysis across both sites. HoNOS is a widely used and clinician- 
reported mental health outcome instrument comprised of 12 
items/subscales, which cover symptom severity, functioning, 
social and environmental measures.8 The HoNOS score is then 
combined with additional risk- based scales to group patients into 
‘clusters’ using the Mental Health Clustering Tool.9 The 21 clus-
ters are divided into three superclasses (psychosis, non- psychosis 
and organic), which are a measure of combined symptomatic- 
functional- social- environmental severity.9 Within each super-
class, the cluster value increases along an ordinal scale, reflecting 
increasing healthcare complexity with correspondingly higher 
costs for the NHS.10
Cohort 1 included patients with at least one HoNOS assess-
ment each year during the index period (ie, 2018, 2019 and 
2020); by contrast, cohort 2 included patients with at least one 
HoNOS assessment during the index period only in 2019 and 
2020. The HoNOS scores were linked to the data from clinical 
visits. If the date of the HoNOS assessment did not match the date 
of the visit as registered in the system, we took the first attended 
diary appointment date within 5 days prior to the HoNOS date. 
If a patient had more than one HoNOS assessment in a given 
year, the most recent assessment was included in the analysis. A 
focus group with senior clinical staff at OHFT was carried out 
to agree on the cluster data analysis and the interpretation of 
the results. For each cohort, we identified patients who did and 
did not move to a different superclass in the years considered. 
Changes in HoNOS scores and clusters were analysed within the 
same superclass. The Friedman test was used to test for statistical 
significance in three or more dependent samples. Where appro-
priate, post hoc analysis for differences between pairs of years 
(eg, 2018–2019, 2019–2020) was conducted using the Wilcoxon 
signed- rank test with Bonferroni correction. Where there were 
only two dependent samples, the Wilcoxon signed- rank test was 
used. An alpha level of 0.001 was preferred in the interpretation 
of statistical test results as recommended and used in real- world 
observational studies of health services.11 12 Statistical analyses 
were performed in Python.
FINDINGS
Impact on service delivery
There were 204 504 registered mental health patients in OHFT 
and 166 702 in SHFT (table 1). Of note, Child and Adoles-
cent Mental Health Service data were not available for SHFT. 
However, most service activity variables, including referral, 
discharge and inpatient measures, were common to the two 
Trusts (table 1; online supplemental appendix, Sections 2 and 5). 
From 2019 to 2020, there was a reduction in measures of turn-
over, such as referrals and discharges, in both SHFT and OHFT 
(table 1). In OHFT, the 2019- to- 2020 change in these measures 
reversed the increasing trend in referral and discharge numbers 
observed from 2018 to 2019, while SHFT experienced yearly 
decrease in referrals and discharges from 2018 to 2020 (table 1). 
Similar yearly trends were found in measures of inpatient service 
Table 1 Aggregate service measures from 2018 to 2020
Oxford Southern
Overall populations served (2020) 1.9 million 1.8 million
Registered in mental health services 204 504 166 702
Open referrals
  2018 66 932 60 076
  2019 75 703 57 804
  2020 74 307 52 164
New referrals 40 899
  2018 46 818 56 498
  2019 42 642 53 863
  2020 48 389
New patients with an accepted referral 27 944
  2018 30 216 39 555
  2019 26 522 37 865
  2020 33 739
Discharges
  2018 39 188 39 710
  2019 45 130 39 395
  2020 44 202 35 523
Scheduled appointments
  2018 244 216 337 946
  2019 253 760 337 893
  2020 292 942 356 909
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turnover at OHFT, while yearly increases in these measures were 
observed at SHFT (online supplemental appendix, table 8A). 
Despite these differences, both Trusts consistently reported a 
large decrease in referrals per month from March to April 2020 
(online supplemental appendix, table 6D and figure 6H) and a 
decrease in number of distinct inpatients in March 2020 (online 
supplemental appendix, table 8C and figure 8A). However, 
monthly referral activity returned to pre- lockdown levels by 
June/July 2020 (online supplemental appendix, table 6D and 
6H).
The total number of scheduled appointments increased in 
2020 (table 1). In OHFT, there was a 15.4% overall increase 
in scheduled appointments from 2019 to 2020, compared with 
a 3.9% increase from 2018 to 2019 (table 1). In SHFT, there 
was a 5.6% increase in scheduled appointments from 2019 to 
2020, compared with a stable number of total appointments 
from 2018 to 2019 (table 1).
Remote consultations
The number of non- face- to- face (remote) appointments—
comprising video and telephone consultations—increased in 
both Trusts during the pandemic, going from 4685 to a peak 
of 26 245 appointments in OHFT and from 7117 to 24 987 
appointments in SHFT, in February to June 2020. The monthly 
averages from April to September 2020 were 23 030 and 22 977 
remote appointments/month in OHFT and SHFT, respectively 
(figure 1). At OHFT video consultations contributed to an 
average of 30.5% of the total telepsychiatric services per month 
from April to September 2020, while, prior to the pandemic, they 
comprised less than 10% (9.1% in February 2020) (figure 2). 
SHFT registered a smaller proportion of video consultations out 
of the total number of telepsychiatry activities (monthly average 
7.6% from April to September 2020), but it is worth noting 
that less than 0.2% of all remote consultations were done by 
video before March 2020 (figure 2). The baseline attendance 
rate in February 2020, regardless of modality, was lower in 
SHFT (78.2% for in- person and 87.1% for remote) than OHFT 
(84.4% and 92.4%, respectively) (figure 3; online supplemental 
appendix, table 6E). Month- by- month analysis showed that 
attendance rate to remote visits decreased between January and 
September 2020 in both Trusts, and at OHFT, it became lower 
than the attendance rate of in- person appointments from May 
2020 onwards (figure 3; online supplemental appendix, table 
6E). After the lockdown, no- show rates increased for remote 
appointments at OHFT (4.6% in February to 8.2% in September 
2020) and decreased for in- person appointments at OHFT 
(from 6.1% to 4.8%) and SHFT (from 9.6% to 7.0%) (online 
supplemental appendix, figure 6J). No- show rates at remote 
appointments at SHFT remained largely stable pre- to- post lock-
down, with a rate of 11.6% in both February and September 
2020 (online supplemental appendix, figure 6J).
The analysis of diagnostic group- level data (based on Interna-
tional Statistical Classification of Diseases and Related Health 
Problems, version 10 codes, or treatment team) showed that the 
ratio of remote to in- person appointments increased from 2019 
to 2020 in all diagnostic groups (online supplemental appendix, 
figure 6C,G). The greatest change was for Eating Disorders 
(from 0.12 to 1.51 and 0.10 to 2.53 at OHFT and SHFT, 
respectively; online supplemental appendix, table 6B,C), with 
other groups, such as mental retardation (2.61), developmental 
disorders (2.20), dementia (2.11) and conduct disorders (2.05) 
to follow (online supplemental appendix, table 6B). For patients 
with dementia at OHFT, non- attendance rates at in- person 
appointments were fourfold higher than remote appointments 
(17.2% vs 3.9%) (online supplemental appendix, Table 6F).
Analysis of HoNOS data
Only OHFT reported HoNOS data. Cohort 1 (2018, 2019, 
2020) comprised 998 patients (online supplemental appendix, 
table 7A). Of them, 792 patients (79.4%) stayed within the same 
superclass: 284 (35.9%) non- psychotic, 174 (22.0%) organic and 
332 (41.9%) psychotic (2 remaining patients were in the ‘vari-
ance cluster’, ie, in need of mental healthcare, but not classified 
into any superclass) (online supplemental appendix, table 7B). 
Analysing the change of clusters within the same superclass, only 
the organic superclass reported a statistically significant differ-
ence in the cluster value between 2018 and 2020 (p<0.001) 
(online supplemental appendix, table 7L). A post hoc pairwise 
Figure 1 Attended face- to- face (F2F) and non- face- to- face (Non- F2F) 
appointments.
Figure 2 Attended appointments by telephone and video.
Figure 3 Attendance rate of face- to- face (F2F) and non- face- to- face 
(Non- F2F) appointments in 2020.
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test showed that the significant increase happened between 2019 
and 2020, but not between 2018 and 2019 (online supplemental 
appendix, table 7N). The results of the cluster analysis were 
supported by the analysis of HoNOS total scores within the same 
superclass (online supplemental appendix, tables 7E, 7F, 7H).
Cohort 2 (2019, 2020) included 2712 patients, of whom 2318 
(85.5%) stayed within the same superclass from 2019 to 2020: 
909 patients (39.2%) were non- psychotic, 687 (29.6%) organic, 
720 (31.1%) psychotic and 2 (0.1%) in the variance cluster 
(online supplemental appendix, tables 7O,P). The analysis of 
clusters within the same superclass showed increased complexity 
in the organic superclass (p<0.001) (online supplemental 
appendix, table 7Z). In these patients, the HoNOS total score 
worsened significantly (p<0.001), while the non- psychotic and 
psychotic superclass showed an improvement in total HoNOS 
score (online supplemental appendix, Table 7U). The complete 
description of HoNOS results is available in the online supple-
mental appendix, Section 7.
DISCUSSION
Our study of two large NHS mental health Trusts demon-
strated a rapid shift to remote service delivery as a result of 
the COVID- 19 pandemic and associated national lockdown. 
These findings are consistent with other published reports.7 13–15 
However, this is the first study assessing the clinical impact on 
mental health services and patients. Taken together, our study 
suggests that remote service activity increased markedly, with 
considerable use of video consultations, but this did not automat-
ically translate to more patients attending the scheduled appoint-
ments. Notably, our findings on non- attendance differ with the 
experience of mental healthcare providers in the USA who have 
reported reductions in tele- mental health no- show rates after 
rapid virtualisation of services.16 17 In contrast, no- show rates 
at remote consultations increased in OHFT and remained stable 
in SHFT after lockdown- related service changes. We could 
not directly compare associated transatlantic clinical outcomes 
due to a dearth of such analyses in the literature. However, 
our study suggests that the impact on service activity is health 
system, region and diagnosis specific. Associated changes in clin-
ical outcomes may also partly reflect such differences, but this 
currently remains a hypothesis to be tested. Importantly, our 
analysis of clinical outcomes shows that they can vary according 
to the broad diagnostic ‘superclasses’ as defined in the UK mental 
healthcare system.
In terms of clinical outcomes, during the pandemic, patients 
belonging to the organic superclass significantly increased in 
healthcare complexity in comparison with previous years. While 
ICD- 10 diagnoses and HoNOS clusters are not exactly the 
same,9 there is up to 76% overlap between the two for inpatients 
with a diagnosis of dementia and organic disorders.18 HoNOS 
scores can be a significant resource to gain insights into mental 
illness and treatment effectiveness.19 These findings are consis-
tent with reports of pandemic- related worsening of behavioural 
and psychological symptoms in people with dementia,20 and can 
have implications for patients, carers and mental health services 
at different levels. While the remote attendance rates of patient 
with dementia were high, the effectiveness and usefulness of 
these consultations have not been established. A recent review 
suggests that remote management of dementia could achieve a 
level of diagnostic accuracy and patient and caregiver satisfaction 
comparable to in- person consultations.21 However, factors such 
as reduced cognitive function, confusion and sensory impair-
ments may reduce the quality of teleconsultations for these 
patients as they may find it difficult to engage with their health-
care clinician using a virtual format.20 Literacy, availability and 
familiarity with the internet may also be an issue. For instance, 
in the UK in 2019, only 47% of adults above 75 years of age 
were considered recent internet users, compared with virtually 
all (99%) adults aged 16–44 years.22 Patient difficulties with 
using technology for telepsychiatry have been reported in both 
the 55–64 and 65–74 year old age groups.17
The eating disorders (ED) group had the greatest relative pre- 
to- post increase in the use of telepsychiatry. Evidence suggests 
that the psychological well- being of individuals with ED has 
been particularly impacted by the pandemic.23 One ED- focused 
service evaluation study showed unexpected benefits of telecon-
ferencing, including increased participation of patients in ther-
apeutic groups and enhanced interdisciplinary communication 
between staff, but stated that significant practical challenges 
remained in the implementation of telepsychiatry for people 
with ED.24
Questions remain about the wider applicability of telepsychi-
atry across the whole spectrum of mental health disorders. For 
personality disorders, schizophrenia and substance misuse diag-
nostic groups, in our study the ratio of remote versus in- person 
appointments was less than 1, indicating greater difficulty of 
remotely managing patients characterised by a more disrup-
tive behavioural component. Further work remains to be done 
in better understanding how telepsychiatry services could be 
improved, and for whom and in what situations different remote 
modalities are most appropriate. This is important, as our study 
suggests, that the rapid shift to remote service delivery has not 
reached some groups of patients who may require more tailored 
management with telepsychiatry. Specific groups of patients 
may require more intensive and/or nuanced management in the 
post- pandemic era of digital psychiatry. Hybrid models of care, 
combining digital psychiatry with face- to- face assessment and 
care coordinators to support patients in overcoming practical 
problems, may be an effective way of managing highly complex 
groups of patients with a more personalised and blended 
approach. The quality, effectiveness and uptake of telepsychiatry 
can be enhanced by training clinicians25 and patients.26 There 
is a need for evidence- based, targeted telepsychiatric training 
programmes to enhance clinical efficacy and health outcomes in 
patients with mental health disorders. Training will be especially 
important not only in terms of assessment of patients via video 
or telephone consultations but also in terms of remote moni-
toring of symptoms27 and delivery of treatment modules.28
The strengths of our study include the size of the dataset, 
comparison across two large NHS mental health Trusts in England 
and the use of patient- level data to characterise the impact of 
the pandemic, using data analysed over 3 years to conduct serial 
comparisons. However, the HoNOS analysis was not replicated 
at SHFT as the Trust does not readily store cluster- level HoNOS 
data in an anonymised format; hence, the patient- level outcomes 
are limited to OHFT. Moreover, the months considered were 
limited to January–September, meaning some significant events, 
such as the second national lockdown (5 November 2020), were 
excluded. Additional studies should be conducted to examine 
the long- term patterns in telepsychiatry use and the impact on 
clinical outcomes beyond the pandemic- associated acute service 
transformation. Furthermore, the findings cannot immediately 
be generalised to populations or healthcare settings outside of 
the Trusts. Patients seen in secondary/specialist mental health 
settings have distinct, often more complex, needs compared with 
those who are treated in primary care mental health settings.29 
Future studies should aim to quantify these differences, adjust 
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for individual and regional socioeconomic factors, and consider 
Trust- specific differences in the structure of teams and delivery 
of mental health services.
This work is primarily a descriptive study of service changes. 
Patient outcomes and various dimensions of the quality of telep-
sychiatric services, such as effectiveness, utility and acceptability, 
cannot be definitively correlated. While we have demonstrated 
that it is feasible to use HoNOS data to assess patient outcomes 
and generate clinically meaningful insights,8 30 the HoNOS has 
been shown to have moderate inter- rater reliability and limited 
validity in relation to patient- reported symptomatology.31
Our work reveals challenges in conducting a study using 
EHR from different mental health Trusts, each one with their 
own data infrastructure. OHFT and SHFT had different local 
EHR systems with some, although relatively minor, varia-
tions in definitions of variables, and the data infrastructure. A 
shared data plan was developed in the protocol and aimed at 
ensuring overall consistency in extracting variables of interest, 
their descriptions and optimising workflow. The collaboration 
required frequent, often separate discussions between individual 
data teams to ensure that analyses represented the same under-
lying variables, produced comparable visualisations and made 
any amendments to reflect theoretical iterations of the project. 
As EHR studies may generate important data- driven insights 
during the COVID- 19 pandemic and beyond, more efficient 
and integrated data infrastructures, such as the development of 
a federated database, are likely to play an increasingly important 
role in the future of mental health research and service improve-
ment processes.32
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